Clinical Research Directory
Browse clinical research sites, groups, and studies.
Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis
Sponsor: Semmelweis University Heart and Vascular Center
Summary
The aim of this open label, randomized study is to compare the safety and efficacy of three different methods to handle coronary drug eluting stent (DES) in-stent restenosis (ISR). These are the: * Magic Touch - sirolimus coated balloon * Emperor - paclitaxel and dextran coated balloon * Xience - chromium-cobalt everolimus eluting stent
Official title: OPtimal TrEatment for CoroNary Drug Eluting Stent In-Stent Restenosis: Paclitaxel Versus Sirolimus Coated Balloons Versus Everolimus Eluting Stents - the OPEN ISR Study
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2021-04-26
Completion Date
2025-01-01
Last Updated
2024-11-22
Healthy Volunteers
No
Conditions
Interventions
Intravascular management of prior implanted coronary drug eluting stent restenosis
Intravascular devices will be assessed for the management of prior implanted drug eluting stent restenosis management.
Locations (2)
Semmelweis University Heart and Vascular Center
Budapest, Budapest, Hungary
University of Szeged, Department of Invasive Cardiology
Szeged, Csongád-Csanád, Hungary